Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Baby cries show evidence of cocaine exposure during pregnancy

  • Bipolar disorder discovery at the nano level

  • Alternate approach to traditional CPR saves lives

  • Teenage self-harm linked to problems in later life

  • Unsteady on your feet? Little touches could make all the difference

  • Genes exhibit different behaviours in different stages of development

  • Susceptibility for relapsing major depressive disorder can be calculated

  • Clinical trial could change standard treatment for stroke

  • Criminologists try to solve murder mystery: Who will become a killer?

  • Association between air toxics, childhood autism

  •